Agree with your comments Boffin, but we still allow statements to be published like this one...
"Bisantrene is an anthracene-based chemotherapy drug originally developed in the 1970s in France, which is known to reduce cardiotoxicity when used with anthracyclines."
this was from this article this week!
https://www.theaustralian.com.au/business/*/content/race-oncology-races-ahead-in-fy24-with-key-milestones/news-story/07d95c364f0aa86ee65bf809ac8c7126
Industry news, page-2156
-
- There are more pages in this discussion • 236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.57 | $387.6K | 237.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 807 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 2376 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |